Source: Anti-Cancer Drugs. Unidade: FMRP
Subjects: APOPTOSE, FÁRMACOS, ANTINEOPLÁSICOS, CARCINOMA, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Kleiton S. et al. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line. Anti-Cancer Drugs, v. 28, n. 6, p. 634-644, 2017Tradução . . Disponível em: https://doi.org/10.1097/cad.0000000000000504. Acesso em: 09 fev. 2026.APA
Borges, K. S., Andrade, A. F., Silveira, V. da S., Marco Antonio, D. S., Vasconcelos, E. J. R., Antonini, S. R. R., et al. (2017). The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line. Anti-Cancer Drugs, 28( 6), 634-644. doi:10.1097/cad.0000000000000504NLM
Borges KS, Andrade AF, Silveira V da S, Marco Antonio DS, Vasconcelos EJR, Antonini SRR, Tone LG, Scrideli CA. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line [Internet]. Anti-Cancer Drugs. 2017 ; 28( 6): 634-644.[citado 2026 fev. 09 ] Available from: https://doi.org/10.1097/cad.0000000000000504Vancouver
Borges KS, Andrade AF, Silveira V da S, Marco Antonio DS, Vasconcelos EJR, Antonini SRR, Tone LG, Scrideli CA. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line [Internet]. Anti-Cancer Drugs. 2017 ; 28( 6): 634-644.[citado 2026 fev. 09 ] Available from: https://doi.org/10.1097/cad.0000000000000504
